Darifenacin - Novartis
Alternative Names: Darifenacin hydrobromide; Emselex; Enablex; UK 88525Latest Information Update: 06 Jun 2024
Price :
$50 *
At a glance
- Originator Pfizer
- Developer AbbVie; Novartis; Pfizer
- Class Benzofurans; Pyrrolidines; Small molecules; Urologics
- Mechanism of Action Muscarinic M3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Overactive bladder
- Discontinued Irritable bowel syndrome; Small cell lung cancer